Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR
Use of a minimalist approach that facilitates early discharge is even more important in the COVID-19 era, experts say.
Discharging patients within 24 hours of a transfemoral TAVR procedure performed without complications appears to be a safe approach, data from a single Italian center suggest. The findings may have implications for patient care in the COVID-19 era, experts say.
There were no differences in rates of mortality or rehospitalization for heart failure through the first year between patients discharged the next day and those who left the hospital later, according to researchers led by Giuliano Costa, MD, and Marco Barbanti, MD (both of Policlinico-Vittorio Emanuele Hospital, University of Catania, Italy).
Patients with a prior permanent pacemaker implant (PPI) and those with a preprocedural CT angiography assessment were more likely to receive next-day discharge, they report in a study published in the August issue of EuroIntervention.
